Journal
Journal of clinical investigation
Publication Date
12-15-2021
Volume
131
Issue
24
First Page
e152670
Document Type
Open Access Publication
DOI
10.1172/JCI152670
Rights and Permissions
Yarchoan M, Cope L, Ruggieri AN, Anders RA, Noonan AM, Goff LW, Goyal L, Lacy J, Li D, Patel AK, He AR, Abou-Alfa GK, Spencer K, Kim EJ, Davis SL, McRee AJ, Kunk PR, Goyal S, Liu Y, Dennison L, Xavier S, Mohan AA, Zhu Q, Wang-Gillam A, Poklepovic A, Chen HX, Sharon E, Lesinski GB, Azad NS. Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers. J Clin Invest. 2021 Dec 15;131(24):e152670. doi: 10.1172/JCI152670.
Recommended Citation
Yarchoan, Mark; Wang-Gillam, Andrea; and et al, "Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers." Journal of clinical investigation. 131, 24. e152670 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11239
